Chimerism and tolerance in transplantation.

PubWeight™: 1.07‹?› | Rank: Top 10%

🔗 View Article (PMC 521985)

Published in Proc Natl Acad Sci U S A on August 19, 2004

Authors

Thomas E Starzl1

Author Affiliations

1: Transplantation Institute, University of Pittsburgh Medical Center, 3459 Fifth Avenue, Pittsburgh, PA 15213, USA. mangantl@msx.upmc.edu

Articles citing this

Antilymphoid antibody preconditioning and tacrolimus monotherapy for pediatric kidney transplantation. J Pediatr (2006) 1.36

Complete differentiation of CD8+ T cells activated locally within the transplanted liver. J Exp Med (2006) 1.25

Microchimerism maintains deletion of the donor cell-specific CD8+ T cell repertoire. J Clin Invest (2006) 1.13

Cell migration from baby to mother. Cell Adh Migr (2007) 0.99

Acquired immunologic tolerance: with particular reference to transplantation. Immunol Res (2007) 0.97

Composite tissue transplantation: a rapidly advancing field. Transplant Proc (2008) 0.92

Dissociation between peripheral blood chimerism and tolerance to hindlimb composite tissue transplants: preferential localization of chimerism in donor bone. Transplantation (2009) 0.87

Immune-privileged embryonic Swiss mouse STO and STO cell-derived progenitor cells: major histocompatibility complex and cell differentiation antigen expression patterns resemble those of human embryonic stem cell lines. Immunology (2006) 0.83

Microchimerism in promoting graft acceptance in clinical transplantation. Curr Opin Organ Transplant (2011) 0.81

Recent advances in renal interstitial fibrosis and tubular atrophy after kidney transplantation. Fibrogenesis Tissue Repair (2014) 0.80

Tolerance and chimerism and allogeneic bone marrow/stem cell transplantation in liver transplantation. World J Gastroenterol (2013) 0.79

Male microchimerism at high levels in peripheral blood mononuclear cells from women with end stage renal disease before kidney transplantation. PLoS One (2012) 0.79

The need for inducing tolerance in vascularized composite allotransplantation. Clin Dev Immunol (2012) 0.79

Back to the future. Transplantation (2005) 0.79

The mystique of organ transplantation. J Am Coll Surg (2005) 0.78

Ingraft chimerism in lung transplantation--a study in a porcine model of obliterative bronchiolitis. Respir Res (2011) 0.76

Donor-derived peripheral mononuclear cell DNA is associated with stable kidney allograft function: a randomized controlled trial. Chimerism (2012) 0.76

A modern Cosmas and Damian: Sir Roy Calne and Thomas Starzl receive the 2012 Lasker~Debakey Clinical Medical Research Award. J Clin Invest (2012) 0.76

Five-year clinical effects of donor bone marrow cells infusions in kidney allograft recipients: improved graft function and higher graft survival. Chimerism (2013) 0.76

Anthony Cerami Award in Translational Medicine: A Journey in Science: The Birth of Organ Transplantation with Particular Reference to Alloengraftment Mechanisms. Mol Med (2015) 0.75

A Novel Model on DST-Induced Transplantation Tolerance by the Transfer of Self-Specific Donor tTregs to a Haplotype-Matched Organ Recipient. Front Immunol (2017) 0.75

Dichotomy between T Cell and B Cell Tolerance to Neonatal Retroviral Infection Permits T Cell Therapy. J Immunol (2016) 0.75

Human leucocyte antigen-defined microchimerism early post-transplant does not predict for stable lung allograft function. Clin Exp Immunol (2013) 0.75

Donor B cells in splenic follicles of experimental pulmonary allograft recipients. Langenbecks Arch Surg (2007) 0.75

Articles cited by this

Actively acquired tolerance of foreign cells. Nature (1953) 19.82

The fate of skin homografts in man. J Anat (1943) 17.30

The behaviour and fate of skin autografts and skin homografts in rabbits: A report to the War Wounds Committee of the Medical Research Council. J Anat (1944) 16.73

FK 506 for liver, kidney, and pancreas transplantation. Lancet (1989) 13.70

Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers. Lancet (1979) 12.29

Cell migration, chimerism, and graft acceptance. Lancet (1992) 12.24

Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells. Nature (1993) 9.81

Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance. Hepatology (1993) 8.76

THE REVERSAL OF REJECTION IN HUMAN RENAL HOMOGRAFTS WITH SUBSEQUENT DEVELOPMENT OF HOMOGRAFT TOLERANCE. Surg Gynecol Obstet (1963) 8.04

The use of heterologous antilymphoid agents in canine renal and liver homotransplantation and in human renal homotransplantation. Surg Gynecol Obstet (1967) 7.24

FACTORS DETERMINING SHORT- AND LONG-TERM SURVIVAL AFTER ORTHOTOPIC LIVER HOMOTRANSPLANTATION IN THE DOG. Surgery (1965) 6.71

Orthotopic homotransplantation of the human liver. Ann Surg (1968) 6.64

Primarily vascularized allografts of hearts in mice. The role of H-2D, H-2K, and non-H-2 antigens in rejection. Transplantation (1973) 6.01

Long survival in rats after multivisceral versus isolated small-bowel allotransplantation under FK 506. Surgery (1991) 5.92

Induction of immunological tolerance by porcine liver allografts. Nature (1969) 5.89

The impact on the developing embryo and newborn animal of adult homologous cells. Acta Pathol Microbiol Scand (1957) 5.02

A simple method for inducing tolerance of skin homografts in mice. Transplant Bull (1957) 4.73

Immunological reconstitution of sex-linked lymphopenic immunological deficiency. Lancet (1968) 4.41

Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology (1994) 4.32

Tolerogenic immunosuppression for organ transplantation. Lancet (2003) 4.09

Production of alpha 1,3-galactosyltransferase-deficient pigs. Science (2002) 3.96

Replacement of donor lymphoid tissue in small-bowel transplants. Lancet (1991) 3.85

Migration of dendritic leukocytes from cardiac allografts into host spleens. A novel pathway for initiation of rejection. J Exp Med (1990) 3.73

Antigen localization and migration in immunity and tolerance. N Engl J Med (1998) 3.71

Drug-induced immunological tolerance. Nature (1959) 3.68

Long-term survival after renal transplantation in humans: (with special reference to histocompatibility matching, thymectomy, homograft glomerulonephritis, heterologous ALG , AND RECIPIENT MALIGNANCY). Ann Surg (1970) 3.48

The enemy within: keeping self-reactive T cells at bay in the periphery. Nat Rev Immunol (2002) 3.47

Chimerism after liver transplantation for type IV glycogen storage disease and type 1 Gaucher's disease. N Engl J Med (1993) 3.36

Fetomaternal leukocyte incompatibility. J Clin Invest (1958) 3.32

Immunobiology of tissue transplantation: a return to the passenger leukocyte concept. Annu Rev Immunol (1983) 3.32

Immunologic 'ignorance' of vascularized organ transplants in the absence of secondary lymphoid tissue. Nat Med (2000) 3.25

On immunological memory. Annu Rev Immunol (1996) 3.21

Chimerism and donor-specific nonreactivity 27 to 29 years after kidney allotransplantation. Transplantation (1993) 3.13

Chronic survival after human renal homotransplantation. Lymphocyte-antigen matching, pathology and influence of thymectomy. Ann Surg (1965) 3.00

Studies of homograft sex and of gamma globulin phenotypes after orthotopic homotransplantation of the human liver. Surg Forum (1969) 2.80

The role of afferent lymphatics in the rejection of skin homografts. J Exp Med (1968) 2.60

Antigen localisation regulates immune responses in a dose- and time-dependent fashion: a geographical view of immune reactivity. Immunol Rev (1997) 2.58

The rejection of renal homografts. Inhibition in dogs by 6-mercaptopurine. Lancet (1960) 2.49

Bone-marrow transplantation in a patient with the Wiskott-Aldrich syndrome. Lancet (1968) 2.29

Isohemagglutinins of graft origin after ABO-unmatched liver transplantation. N Engl J Med (1984) 2.25

Transplantation milestones. Viewed with one- and two-way paradigms of tolerance. JAMA (1995) 2.20

Graft-versus-host disease after brown Norway-to-Lewis and Lewis-to-Brown Norway rat intestinal transplantation under FK506. Transplantation (1993) 2.14

Prolonged survival of liver transplants in the pig. Br Med J (1967) 2.14

Study on transplantation immunity after total body irradiation: clinical and experimental investigation. Surgery (1960) 2.07

Transplantation tolerance from a historical perspective. Nat Rev Immunol (2001) 2.04

Presence of hematopoietic stem cells in the adult liver. Nat Med (1996) 2.00

Kidney transplants in mice. An analysis of the immune status of mice bearing long-term, H-2 incompatible transplants. J Exp Med (1978) 1.95

Induction of tolerance to a canine renal homotransplant with 6-mercaptopurine. Lancet (1962) 1.89

Analysis of HL-A incompatibility in human renal transplants. Tissue Antigens (1971) 1.89

Lymphocyte traffic and graft-versus-host disease after fully allogeneic small bowel transplantation. Transplant Proc (1991) 1.89

Transfer of symptomatic peanut allergy to the recipient of a combined liver-and-kidney transplant. N Engl J Med (1997) 1.83

ANALYSIS OF MECHANISM OF IMMUNOSUPPRESSIVE DRUGS IN RENAL HOMOTRANSPLANTATION. Ann Surg (1964) 1.81

The saga of liver replacement, with particular reference to the reciprocal influence of liver and kidney transplantation (1955-1967). J Am Coll Surg (2002) 1.81

Early events in liver allograft rejection. Delineation of sites of simultaneous intragraft and recipient lymphoid tissue sensitization. Am J Pathol (1991) 1.78

The discovery of MHC restriction. Immunol Today (1997) 1.76

Leucocyte antibodies in sera from pregnant women. Nature (1958) 1.75

Fully allogeneic liver grafting in rats induces a state of systemic nonreactivity to donor transplantation antigens. Transplantation (1980) 1.71

[Iso-leuko-antibodies]. Acta Haematol (1959) 1.69

The homotransplantation of kidneys and of fetal liver and spleen after total body irradiation. Ann Surg (1960) 1.68

Multilineage hematopoietic reconstitution of supralethally irradiated rats by syngeneic whole organ transplantation. With oarticular reference to the liver. Transplantation (1996) 1.65

Mortality and skin transplantability in x-irradiated mice receiving isologous, homologous or heterologous bone marrow. Proc Soc Exp Biol Med (1957) 1.62

A short course of methylprednisolone immunosuppression inhibits both rejection and spontaneous acceptance of rat liver allografts. Transplantation (2001) 1.61

The effects of 6-mercaptopurine on homograft reactions. J Clin Invest (1960) 1.61

On the key role of secondary lymphoid organs in antiviral immune responses studied in alymphoplastic (aly/aly) and spleenless (Hox11(-)/-) mutant mice. J Exp Med (1997) 1.59

HAEMATOPOIETIC CHIMERA IN MAN AFTER ALLOGENIC (HOMOLOGOUS) BONE-MARROW TRANSPLANTATION. (CONTROL OF THE SECONDARY SYNDROME. SPECIFIC TOLERANCE DUE TO THE CHIMERISM). Br Med J (1963) 1.59

Kidney transplantation under a tolerogenic regimen of recipient pretreatment and low-dose postoperative immunosuppression with subsequent weaning. Ann Surg (2003) 1.52

The complementary roles of deletion and regulation in transplantation tolerance. Nat Rev Immunol (2003) 1.50

A functioning kidney homotransplant in the dog. Surgery (1959) 1.45

[Orthotopic liver graft in pigs. 1st results]. Mem Acad Chir (Paris) (1966) 1.35

Use of a probe to repeat sequence of the Y chromosome for detection of host cells in peripheral blood of bone marrow transplant recipients. Am J Clin Pathol (1991) 1.35

Lymphoid/nonlymphoid compartmentalization of donor leukocyte chimerism in rat recipients of heart allografts, with or without adjunct bone marrow. Transplantation (1998) 1.22

Redistribution of renal allograft-responding leukocytes during rejection. II. Kinetics and specificity. J Exp Med (1982) 1.21

The prolongation of functional survival of canine renal homografts by 6-mercaptopurine. Surg Forum (1960) 1.19

Antiviral immunity. Immunol Today (1997) 1.19

Adult tolerance induced by 6-methyl mercaptopurine to a canine renal homograft. Nature (1963) 1.17

What we have learned about heart transplants. J Thorac Cardiovasc Surg (1968) 1.13

Donor hematopoietic progenitor cells in nonmyeloablated rat recipients of allogeneic bone marrow and liver grafts. Transplantation (1999) 1.04

Orthotopic liver allografts in the rat. The influence of strain combination on the fate of the graft. Transplantation (1984) 1.00

The chemistry and biochemistry of purine analogs. Ann N Y Acad Sci (1954) 0.95

Lessons of organ-induced tolerance learned from historical clinical experience. Transplantation (2004) 0.94

Explanation for loss of the HLA matching effect. Transplant Proc (1995) 0.91

Allografts surviving for 26 to 29 years following living-related kidney transplantation: analysis by light microscopy, in situ hybridization for the Y chromosome, and anti-HLA antibodies. Am J Kidney Dis (1994) 0.90

Liver transplants contribute to their own success. Nat Med (1996) 0.89

The birth of clinical organ transplantation. J Am Coll Surg (2001) 0.76